Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate
Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow reinvestment rate. Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Cash Flow Reinvestment Rate of 2.29x as of December 2024, reinvesting CN¥107.98 Million (capex CN¥105.31 Million plus investments CN¥-2.66 Million) from operating cash flow of CN¥47.07 Million. See Suzhou Fushilai Pharmaceutical Co. Ltd. leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Cash flow reinvestment rate of Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. Historical reinvestment intensity for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Explore cash flow to debt ratio of Suzhou Fushilai Pharmaceutical Co. Ltd. to assess how comfortably operating cash covers total debt obligations.
Suzhou Fushilai Pharmaceutical Co. Ltd. Cash Flow Reinvestment Rate by Year (2019–2024)
Suzhou Fushilai Pharmaceutical Co. Ltd. cash flow reinvestment rate by year from 2019 to 2024. Year-by-year capital reinvestment analysis for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full cash flow conversion analysis, see 301258 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.29x | CN¥107.98 Million | CN¥47.07 Million | CN¥105.31 Million | ▲ +60.6% |
| 2023 | 1.43x | CN¥135.38 Million | CN¥94.77 Million | CN¥41.62 Million | ▼ -82.4% |
| 2022 | 8.10x | CN¥1.22 Billion | CN¥151.19 Million | CN¥50.11 Million | ▲ +1358.8% |
| 2021 | 0.56x | CN¥110.87 Million | CN¥199.73 Million | CN¥80.75 Million | ▼ -57.8% |
| 2020 | 1.32x | CN¥219.57 Million | CN¥166.85 Million | CN¥65.69 Million | ▲ +17.6% |
| 2019 | 1.12x | CN¥168.45 Million | CN¥150.55 Million | CN¥70.93 Million | — |